On January 10, 2024, the Connecticut for Accessible Psychedelic Medicine (CAPM) held an online and in person forum with lawmakers and experts in Hartford, Connecticut.
The organization, Connecticut for Accessible Psychedelic Medicine (CAPM) hosted an in person and online public forum in regard to psilocybin mushroom decriminalization (1). The event took place between 10am to 12pm EST. From 12pm to 2pm EST, there will be a public comment period offered and takes place in Hartford, the state capitol of Connecticut (1). It can also be viewed on the Connecticut Network where it will be live streamed as well (1).
As mentioned in Psychedelic Week, the invited speakers in the morning session of the event included (1):
In 2023, a bill to decriminalize psilocybin partially in small amounts, passed the Connecticut House by a 86-64 vote (1). Unfortunately, the bill expired before gaining the chance to receive a final vote from the Senate. Representative Steve Stafstrom has plans to reintroduce the bill some time in 2024 (1). If the bill had passed legislation, it would have imposed a $150 fine but end a criminal penalty for having the possession of under a half an ounce of mushrooms. Some concerns have risen to the surface over law enforcement potentially seeking a boost in policing. These concerns have been raised by the New England Veterans for Plant Medicine and Bay Staters for Natural Medicine (1). Hopefully in 2024, the psilocybin decriminalization bill will be passed in the Connecticut Senate and be established into law.
Reference
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.